Skip to main content
SpringerLink
Log in

Clinical Manifestations of Choroidal Neovascularization in AMD

  • Chapter
  • First Online:
Age-related Macular Degeneration

Abstract

Choroidal neovascularization (CNV) presents with a variety of visual symptoms and signs that can serve as clues to the proper diagnosis [1–3]. The physical invasion of blood vessels and associated cellular infiltrate distorts retinal tissue. Associated leakage, bleeding, and eventual scarring can have profound effects on macular function. Recognition of the presence of CNV is fairly easy in advanced cases, but by then, there often is severe vision loss. CNV secondary to age-related macular degeneration (AMD) used to be the leading cause of legal blindness among older adults [4]. With modern treatments aimed against vascular endothelial growth factor (VEGF), the visual acuity in a large majority of patients can be stabilized over the long term, but visual acuity improvement occurs in a minority of patients [5, 6]. Therefore, early diagnosis, prior to the patient suffering severe loss of vision, is the best hope of maintaining visual function in these older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483–492

    Article  PubMed  CAS  Google Scholar 

  2. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 12(358):2606–2617

    Article  Google Scholar 

  3. Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL (1986) Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 104:513–514

    Article  PubMed  CAS  Google Scholar 

  4. Kahn HA, Leibowitz HM, Ganley JP et al (1977) The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 106:17–32

    PubMed  CAS  Google Scholar 

  5. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  PubMed  CAS  Google Scholar 

  6. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444

    Article  PubMed  CAS  Google Scholar 

  7. Treatment of Age-Related Macular Degeneration with Photo­dynamic Therapy (TAP) Study Group (1999) ­Photo­dynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Arch Ophthalmol 117:1329–1345

    Google Scholar 

  8. Yang SS, Fu AD, McDonald HR, Johnson RN, Ai E, Jumper JM (2003) Massive spontaneous choroidal hemorrhage. Retina 23:139–144

    Article  PubMed  Google Scholar 

  9. Lamoureux EL, Hassell JB, Keeffe JE (2004) The determinants of participation in activities of daily living in people with impaired vision. Am J Ophthalmol 137:265–270

    Article  PubMed  Google Scholar 

  10. Lee PP, Cunningham WE, Nakazono TT, Hays RD (2009) Associations of eye diseases and symptoms with self-reported physical and mental health. Am J Ophthalmol 148:804–808.e1

    Article  PubMed  Google Scholar 

  11. Brown GC, Sharma S, Brown MM, Kistler J (2000) Utility values and age-related macular degeneration. Arch Ophth­almol 118:47–51

    Article  PubMed  CAS  Google Scholar 

  12. Marmor MF (2000) A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler. Surv Ophthalmol 44:343–353

    Article  PubMed  CAS  Google Scholar 

  13. Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P (2005) Comparison of the original Amsler grid with the modified Amsler grid. Results for patients with age-related macular degeneration. Retina 25:443–445

    Article  PubMed  Google Scholar 

  14. Wall M, May DR (1987) Threshold Amsler grid testing in maculopathies. Ophthalmology 94:1126–1133

    PubMed  CAS  Google Scholar 

  15. Schuchard RA (1993) Validity and interpretation of Amsler grid reports. Arch Ophthalmol 111(6):776–780

    Article  PubMed  CAS  Google Scholar 

  16. Crossland M, Rubin G (2007) The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol 91:391–393

    Article  PubMed  Google Scholar 

  17. Loewenstein A, Malach R, Goldstein M et al (2003) Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthal­mology 110:966–970

    Article  PubMed  Google Scholar 

  18. Coscas F, Coscas G, Souied E, Tick S, Soubrane G (2007) Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 144:592–599

    Article  PubMed  Google Scholar 

  19. Goldstein M, Loewenstein A, Barak A et al (2005) Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 25:296–303

    Article  PubMed  Google Scholar 

  20. Achard OA, Safran AB, Duret FC, Ragama E (1995) Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 120(3):322–329

    PubMed  CAS  Google Scholar 

  21. Alster Y, Bressler NM, Bressler SB et al (2005) Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 112:1758–1765

    Article  PubMed  Google Scholar 

  22. Fujii GY, De Juan E, Jr HMS, Sunness JS, Chang TS, Rossi JV (2003) Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136:1067–1078

    Article  PubMed  Google Scholar 

  23. Gass JD, Agarwal A, Lavina AM, Tawansy KA (2003) Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23:741–751

    Article  PubMed  Google Scholar 

  24. Tolentino MJ, Miller JW, Gragoudas ES et al (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–1828

    PubMed  CAS  Google Scholar 

  25. Grossniklaus HE, Gass JD (1998) Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 126:59–69

    Article  PubMed  CAS  Google Scholar 

  26. Sawa M, Ober MD, Spaide RF (2006) Autofluorescence and retinal pigment epithelial atrophy after subretinal hemorrhage. Retina 26:119–120

    Article  PubMed  Google Scholar 

  27. Spaide RF, Goldbaum M, Wong DW, Tang KC, Iida T (2003) Serous detachment of the retina. Retina 23:820–846

    Article  PubMed  Google Scholar 

  28. Ting TD, Oh M, Cox TA, Meyer CH, Toth CA (2002) Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 120:731–737

    Article  PubMed  Google Scholar 

  29. Spaide RF (2009) Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 147:644–652

    Article  PubMed  Google Scholar 

  30. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100–110

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vitreous-Retina-Macula Consultants of New York, Manhattan Eye, Ear, and Throat Hospital, New York, NY, USA

    R. F. Spaide

Authors
  1. R. F. Spaide
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. F. Spaide .

Editor information

Editors and Affiliations

  1. Universitäts-Augenklinik Bonn, Universitätsklinikum Bonn, Ernst-Abbe-Str. 2, Bonn, 53127, Germany

    Frank G. Holz

  2. Zentrum für Refraktive Chirurgie, Hohenzollern-Klinik, Hohenzollernring 57, Münster, 48145, Germany

    Daniel Pauleikhoff

  3. Consultants of New York, Vitreous, Retina & Macula, Park Avenue 460, New York, 10022, New York, USA

    Richard F. Spaide

  4. , Deptartment of Ophthalmology, Moorfields Eye Hospital, City Road, London, EC1V 2PD, United Kingdom

    Alan C. Bird

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Spaide, R.F. (2013). Clinical Manifestations of Choroidal Neovascularization in AMD. In: Holz, F., Pauleikhoff, D., Spaide, R., Bird, A. (eds) Age-related Macular Degeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22107-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-22107-1_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-22106-4

  • Online ISBN: 978-3-642-22107-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation